Literature DB >> 23207296

The importance of the N-terminus of T7 endonuclease I in the interaction with DNA junctions.

Alasdair D J Freeman1, Anne-Cécile Déclais, David M J Lilley.   

Abstract

T7 endonuclease I is a dimeric nuclease that is selective for four-way DNA junctions. Previous crystallographic studies have found that the N-terminal 16 amino acids are not visible, neither in the presence nor in the absence of DNA. We have now investigated the effect of deleting the N-terminus completely or partially. N-terminal deleted enzyme binds more tightly to DNA junctions but cleaves them more slowly. While deletion of the N-terminus does not measurably affect the global structure of the complex, the presence of the peptide is required to generate a local opening at the center of the DNA junction that is observed by 2-aminopurine fluorescence. Complete deletion of the peptide leads to a cleavage rate that is 3 orders of magnitude slower and an activation enthalpy that is 3-fold higher, suggesting that the most important interaction of the peptide is with the reaction transition state. Taken together, these data point to an important role of the N-terminus in generating a central opening of the junction that is required for the cleavage reaction to proceed properly. In the absence of this, we find that a cruciform junction is no longer subject to bilateral cleavage, but instead, just one strand is cleaved. Thus, the N-terminus is required for a productive resolution of the junction.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207296     DOI: 10.1016/j.jmb.2012.11.029

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

Review 1.  Interaction of Proteins with Inverted Repeats and Cruciform Structures in Nucleic Acids.

Authors:  Richard P Bowater; Natália Bohálová; Václav Brázda
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

Review 2.  Holliday junction resolvases.

Authors:  Haley D M Wyatt; Stephen C West
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-09-02       Impact factor: 10.005

Review 3.  Making the bend: DNA tertiary structure and protein-DNA interactions.

Authors:  Sabrina Harteis; Sabine Schneider
Journal:  Int J Mol Sci       Date:  2014-07-14       Impact factor: 5.923

4.  Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases.

Authors:  Léna Vouillot; Aurore Thélie; Nicolas Pollet
Journal:  G3 (Bethesda)       Date:  2015-01-07       Impact factor: 3.154

5.  Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells.

Authors:  Haixia Gong; Menglin Liu; Jeff Klomp; Bradley J Merrill; Jalees Rehman; Asrar B Malik
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

6.  Search and processing of Holliday junctions within long DNA by junction-resolving enzymes.

Authors:  Artur P Kaczmarczyk; Anne-Cécile Déclais; Matthew D Newton; Simon J Boulton; David M J Lilley; David S Rueda
Journal:  Nat Commun       Date:  2022-10-07       Impact factor: 17.694

7.  crAssphage is not associated with diarrhoea and has high genetic diversity.

Authors:  Y Y Liang; W Zhang; Y G Tong; S P Chen
Journal:  Epidemiol Infect       Date:  2016-12       Impact factor: 4.434

8.  Analysis of the Intrinsically Disordered N-Terminus of the DNA Junction-Resolving Enzyme T7 Endonuclease I: Identification of Structure Formed upon DNA Binding.

Authors:  Alasdair D J Freeman; Michael Stevens; Anne-Cecile Declais; Adam Leahy; Katherine Mackay; Hassane El Mkami; David M J Lilley; David G Norman
Journal:  Biochemistry       Date:  2016-07-18       Impact factor: 3.162

9.  Junction resolving enzymes use multivalency to keep the Holliday junction dynamic.

Authors:  Ruobo Zhou; Olivia Yang; Anne-Cécile Déclais; Hyeonseok Jin; Gwang Hyeon Gwon; Alasdair D J Freeman; Yunje Cho; David M J Lilley; Taekjip Ha
Journal:  Nat Chem Biol       Date:  2019-01-21       Impact factor: 15.040

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.